ClinConnect ClinConnect Logo
Search / Trial NCT06480422

Combined Effects Of Autogenic Drainage and Segmental Breathing Techniques in Chronic Obstructive Pulmonary Disease

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 24, 2024

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Autogenic Drainage, Segmental Breathing Technique Chronic Obstructive Pulmonary Disease.

ClinConnect Summary

This clinical trial is studying how two breathing techniques—autogenic drainage and segmental breathing—can help people with chronic obstructive pulmonary disease (COPD). COPD is a serious lung condition that makes it hard to breathe and can cause tiredness. In this study, researchers will look at how combining these two breathing exercises affects patients' ability to breathe better and feel more comfortable. They will recruit 40 participants aged 40 to 60 who have been diagnosed with moderate COPD. To be eligible, they should be stable, able to understand the trial information in English or Urdu, and not have certain serious health conditions.

Participants will be divided into two groups. One group will practice both breathing techniques for about 20 to 45 minutes, three times a week over four weeks, while the other group will only do autogenic drainage. Before and after the training, the researchers will measure how well participants are breathing using simple tests. This study aims to find out if the combination of these techniques can lead to better breathing and overall health for individuals with COPD.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 40 - 60 years.
  • Diagnosed moderate COPD patients according to GOLD criteria.
  • FEV / FVC ratio \< 70 years
  • Stable patients can understand written and oral english,urdu trial information.
  • Exclusion Criteria:
  • Pregnancy, due to the Pressure on pelvic and Abdomen muscles.
  • Malignant disease
  • Severe (RA)
  • Diagnosis of Asthma and major diseases, functionally limiting diseases, life expectancy \< 3 months.
  • Neurological disorders

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Sidra Afzal, PP-DPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported